Загрузка...
LKB1/STK11 is a tumor suppressor in the progression of myeloproliferative neoplasms
The myeloproliferative neoplasms frequently progress to blast phase disease, an aggressive form of acute myeloid leukemia. To identify genes that suppress disease progression, we performed a focused CRISPR/Cas9 screen and discovered that depletion of LKB1/Stk11 led to enhanced in vitro self-renewal...
Сохранить в:
| Опубликовано в: : | Cancer Discov |
|---|---|
| Главные авторы: | , , , , , , , , , , , , , , , , , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2021
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8178182/ https://ncbi.nlm.nih.gov/pubmed/33579786 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/2159-8290.CD-20-1353 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|